Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 80-87

  Garcia Bates, Tatiana M ^a   Cordeiro, Marli T ^b   Nascimento, Eduardo J M ^a   Smith, Amanda P ^a   De Melo, Kléia M Soares ^a,b   McBurney, Sean P ^a,c   Evans, Jared D ^a,c   Marques, Ernesto T A ^a,b   Barratt Boyes, Simon M ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BRAZIL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS 3; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIMARY INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; VIRUS REACTIVATION;

EID: 84871827496     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103350     Document Type: Article

References (57)

1. Simmons C. P., J. J. Farrar, V. Nguyen, and B. Wills. 2012 Dengue. N. Engl. J. Med. 366: 1423-1432
2. Halstead, S. B. 2007. Dengue. Lancet 370: 1644-1652. (Pubitemid 350052290)
3. Sabin A. B. 1952 Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1: 30-50
4. Burke, D. S., A. Nisalak, D. E. Johnson, and R. M. Scott. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38: 172-180. (Pubitemid 18036130)
5. Endy, T. P., S. Chunsuttiwat, A. Nisalak, D. H. Libraty, S. Green, A. L. Rothman, D. W. Vaughn, and F. A. Ennis. 2002. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156: 40-51. (Pubitemid 34680622)
6. Graham, R. R., M. Juffrie, R. Tan, C. G. Hayes, I. Laksono, C. Ma'roef, Erlin, K. R. Sutaryo, Porter, and S. B. Halstead. 1999. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia. I. Studies in 1995-1996. Am. J. Trop. Med. Hyg. 61: 412-419. (Pubitemid 29428712)
7. Guzmán M. G., G. Kouri, L. Valdes, J. Bravo, M. Alvarez, S. Vazques, I. Delgado, and S. B. Halstead. 2000 Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152: 793-799, discussion 804.
8. Halstead, S. B., N. T. Lan, T. T. Myint, T. N. Shwe, A. Nisalak, S. Kalyanarooj, S. Nimmannitya, S. Soegijanto, D. W. Vaughn, and T. P. Endy. 2002. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg. Infect. Dis. 8: 1474-1479. (Pubitemid 36008787)
9. Halstead S. B. 1970 Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42: 350-362
10. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146: 201-217. (Pubitemid 8139503)
11. Chau T. N., N. T. Quyen, T. T. Thuy, N. M. Tuan, D. M. Hoang, N. T. Dung, B. Lien, N. T. Quy, N. T. Hieu, L. T. Hieu, et al. 2008 Dengue in Vietnamese infants: results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 198: 516-524
12. Kliks, S. C., S. Nimmanitya, A. Nisalak, and D. S. Burke. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38: 411-419. (Pubitemid 18086128)
13. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144: 3183-3186. (Pubitemid 20149498)
14. Kliks S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989 Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444- 451.
15. Crill W. D., H. R. Hughes, M. J. Delorey, and G. J. Chang. 2009 Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One 4: e4991.
16. Lai C. Y., W. Y. Tsai, S. R. Lin, C. L. Kao, H. P. Hu, C. C. King, H. C. Wu, G. J. Chang, and W. K. Wang. 2008 Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly crossreactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 82: 6631-6643
17. Wahala W. M., A. A. Kraus, L. B. Haymore, M. A. Accavitti-Loper, and A. M. de Silva. 2009 Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392: 103-113
18. Beltramello M., K. L. Williams, C. P. Simmons, A. Macagno, L. Simonelli, N. T. Quyen, S. Sukupolvi-Petty, E. Navarro-Sanchez, P. R. Young, A. M. de Silva, et al. 2010 The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271-283
19. Schieffelin J. S., J. M. Costin, C. O. Nicholson, N. M. Orgeron, K. A. Fontaine, S. Isern, S. F. Michael, and J. E. Robinson. 2010 Neutralizing and nonneutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol. J. 7: 28.
20. Mathew A., K. West, S.Kalayanarooj, R. V. Gibbons, A. Srikiatkhachorn, S.Green, D. Libraty, S. Jaiswal, and A. L. Rothman. 2011 B-cell responses during primary and secondary dengue virus infections in humans. J. Infect. Dis. 204: 1514-1522
21. Balakrishnan T., D. B. Bela-Ong, Y. X. Toh, M. Flamand, S. Devi, M. B. Koh, M. L. Hibberd, E. E. Ooi, J. G. Low, Y. S. Leo, et al. 2011 Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One 6: e29430.
22. Wrammert J., N. Onlamoon, R. S. Akondy, G. C. Perng, K. Polsrila, A. Chandele, M. Kwissa, B. Pulendran, P. C. Wilson, O. Wittawatmongkol, et al. 2012 Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 86: 2911-2918
23. Zompi S., M. Montoya, M. O. Pohl, A. Balmaseda, and E. Harris. 2012 Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl. Trop. Dis. 6: e1568.
24. Rothman A. L. 2011 Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11: 532-543
25. Cordeiro, M. T., A. M. Silva, C. A. Brito, E. J. Nascimento, M. C. Magalha? es, G. F. Guimarães, N. Lucena-Silva, E. M. de Carvalho, and E. T. Marques, Jr. 2007. Characterization of a dengue patient cohort in Recife, Brazil. Am. J. Trop. Med. Hyg. 77: 1128-1134. (Pubitemid 351837806)
26. Cordeiro M. T., U. Braga-Neto, R. M. Nogueira, and E. T. Marques, Jr. 2009 Reliable classifier to differentiate primary and secondary acute dengue infection based on IgG ELISA. PLoS One 4: e4945.
27. WHO. 1997 Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd Ed. World Health Organization, Geneva, Switzerland.
28. Brazil Ministry of Health. 2005 Dengue: Diagnostico e Manejo Clinico, 2nd Ed. Ministerio da Saude (Brasil), Brasilia.
29. Siqueira J. B., L. C. Vinhal, R. F. C. Said, J. L. Hoffmann, J. Martins, S. B. Barbiratto, and G. E. Coelho. 2011 Dengue no Brasil: Tendencias e madancas na epidemiologia, com enfase nas epidemias de 2008 e 2010. In Saude Brasil 2010. Ministerio da Saude (Brasil), Brasilia, p. 157-171.
30. Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171: 4969-4973. (Pubitemid 37432774)
31. de Melo A. B., Mda. P. da Silva, M. C. Magalhães, L. H. Gonzales Gil, E. M. Freese de Carvalho, U. M. Braga-Neto, G. R. Bertani, E. T. Marques, Jr., and M. T. Cordeiro. 2011 Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil. Am. J. Trop. Med. Hyg. 85: 739-747
32. Myint, K. S., T. P. Endy, D. Mongkolsirichaikul, C. Manomuth, S. Kalayanarooj, D. W. Vaughn, A. Nisalak, S. Green, A. L. Rothman, F. A. Ennis, and D. H. Libraty. 2006. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J. Infect. Dis. 194: 600-607. (Pubitemid 44297845)
33. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927. (Pubitemid 36889936)
34. Moir S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, S. Kottilil, J. Arthos, M. A. Proschan, et al. 2008 Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIVinfected viremic individuals. J. Exp. Med. 205: 1797-1805
35. Qian Y., C. Wei, F. Eun-Hyung Lee, J. Campbell, J. Halliley, J. A. Lee, J. Cai, Y. M. Kong, E. Sadat, E. Thomson, et al. 2010 Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 78(Suppl. 1): S69-S82.
36. Kyu S. Y., J. Kobie, H. Yang, M. S. Zand, D. J. Topham, S. A. Quataert, I. Sanz, and F. E. Lee. 2009 Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J. Immunol. Methods 340: 42-47
37. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120: 653-669. (Pubitemid 15210730)
38. Rodriguez-Barraquer I., M. T. Cordeiro, C. Braga, W. V. de Souza, E. T. Marques, and D. A. Cummings. 2011 From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Negl. Trop. Dis. 5: e935.
39. Green, S., D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B. L. Innis, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179: 755-762. (Pubitemid 29159319)
40. Mathew A., and A. L. Rothman. 2008 Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225: 300-313
41. Avirutnan P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, et al. 2006 Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193: 1078-1088
42. Zivna, I., S. Green, D. W. Vaughn, S. Kalayanarooj, H. A. Stephens, D. Chandanayingyong, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168: 5959-5965. (Pubitemid 34556187)
43. Kurane I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F. A. Ennis. 1991 Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 88: 1473- 1480.
44. Simmons, C. P., S. Popper, C. Dolocek, T. N. Chau, M. Griffiths, N. T. Dung, T. H. Long, D. M. Hoang, N. V. Chau, T. T. Thao, et al. 2007. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 195: 1097-1107. (Pubitemid 46543440)
45. Thai K. T., J. A. Wismeijer, C. Zumpolle, M. D. de Jong, M. J. Kersten, and P. J. de Vries. 2011 High incidence of peripheral blood plasmacytosis in patients with dengue virus infection. Clin. Microbiol. Infect. 17: 1823-1828
46. Gawoski, J. M., and W. W. Ooi. 2003. Dengue fever mimicking plasma cell leukemia. Arch. Pathol. Lab. Med. 127: 1026-1027. (Pubitemid 36994867)
47. Halstead, S. B., S. Rojanasuphot, and N. Sangkawibha. 1983. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32: 154-156. (Pubitemid 13186851)
48. Midgley C. M., M. Bajwa-Joseph, S. Vasanawathana, W. Limpitikul, B. Wills, A. Flanagan, E. Waiyaiya, H. B. Tran, A. E. Cowper, P. Chotiyarnwong, et al. 2011 An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85: 410-421
49. Siqueira J. B., Jr., C. M. Martelli, G. E. Coelho, A. C. Simplicio, and D. L. Hatch. 2005 Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerg. Infect. Dis. 11: 48-53
50. Balmaseda, A., S. N. Hammond, Y. Tellez, L. Imhoff, Y. Rodriguez, S. I. Saborío, J. C. Mercado, L. Perez, E. Videa, E. Almanza, et al. 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop. Med. Int. Health 11: 935-942. (Pubitemid 43846454)
51. Balmaseda A., K. Standish, J. C. Mercado, J. C. Matute, Y. Tellez, S. Saborío, S. N. Hammond, A. Nuñez, W. Avilés, M. R. Henn, et al. 2010 Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J. Infect. Dis. 201: 5-14
52. Hammond, S. N., A. Balmaseda, L. Pérez, Y. Tellez, S. I. Saborío, J. C. Mercado, E. Videa, Y. Rodriguez, M. A. Pérez, R. Cuadra, et al. 2005. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am. J. Trop. Med. Hyg. 73: 1063-1070. (Pubitemid 43038255)
53. Kuan G., A. Gordon, W. Avilés, O. Ortega, S. N. Hammond, D. Elizondo, A. Nuñez, J. Coloma, A. Balmaseda, and E. Harris. 2009 The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am. J. Epidemiol. 170: 120- 129.
54. Zompi S., B. H. Santich, P. R. Beatty, and E. Harris. 2012 Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J. Immunol. 188: 404-416
55. Green S., D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, A. L. Rothman, and F. A. Ennis. 1999 Elevated plasma interleukin- 10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59: 329- 334.
56. Nguyen T. H., H. Y. Lei, T. L. Nguyen, Y. S. Lin, K. J. Huang, B. L. Le, C. F. Lin, T. M. Yeh, Q. H. Do, T. Q. Vu, et al. 2004 Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189: 221-232
57. Devignot S., C. Sapet, V. Duong, A. Bergon, P. Rihet, S. Ong, P. T. Lorn, N. Chroeung, S. Ngeav, H. J. Tolou, et al. 2010 Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One 5: e11671.